Alternative image

Medical Devices

Unlocking growth in the medical devices market

At Evonik, we are committed to advancing the medical devices market, which is not only attractive but also poised for significant growth. According to an industry report by BioSpace, the market was valued at USD 640 billion in 2024 and is projected to soar to USD 1.15 trillion by 2034, presenting unparalleled opportunities. The anticipated growth at a compound annual growth rate (CAGR) of 6% from 2024 to 2034 underscores its vibrancy and potential.

Indeed, the medical devices industry is undergoing significant transformation, driven by a shift towards a continuum-of-care model that emphasizes providing personalized and patient-specific solutions across different settings and stages of life. As the global population ages, there is an increasing demand for innovative technologies tailored to individual patient needs. Advances in areas such as digitalization and robotics are enhancing precision and efficiency in medical devices with increasing complexity, leading to improved patient outcomes and experiences.

Alternative image

Additionally, the pressure to reduce costs is prompting manufacturers to streamline operations and simplify supply chains, while regionalization efforts bolster supply security and responsiveness. At Evonik, we take pride in our global footprint, which allows us to manage our supply chain effectively and support the evolving needs of the medical devices market. We are committed to driving innovations that reflect these trends and enhance the standard of patient-centric care.

News

Your Innovation Hub for Next-Generation Biomaterials to Create a Life Beyond Limits.

A strong partner for innovating life-changing medical devices. For more than 50 years Evonik has served customers worldwide with innovative materials and services for medical devices. With our global team of experts we support you at every stage of your product development. We offer a comprehensive portfolio of standard and customized biomaterials and value adding services that open up new possibilities for patient-specific treatment, empowering our customers to bring their ideas to life.

Tailored materials and services for medical devices

Evonik provides a wide range of biomaterial-based solutions for the medical devices market. Our next-generation biomaterials are designed to meet the evolving demands of this sector, empowering our customers to swiftly bring impactful medical technologies to market. We offer comprehensive system solutions that include customization, advanced processing platforms, extensive application expertise, and robust regulatory support, all aimed at facilitating the development of cutting-edge medical devices. Our commitment to enhancing patient outcomes underscores the positive impact our materials have on people’s lives, reflecting our dedication to advancing the field of medical technology.

Rooted in science, driven by continuous innovation, and relentlessly committed to the United Nations Sustainable Development Goals, we empower our customers to accelerate time-to-market for new medical technologies that create life beyond limits.

Evonik's portfolio of biomaterials for medical devices

RESOMER®

... is a biodegradable polymer that is widely used in the medical technology industry. It is known for its excellent biocompatibility, controlled degradation, and tunable properties, making it an ideal material for medical applications.

VESTAKEEP® PEEK

...grades for implants, dental applications and medical devices are changing standards for medical technology applications due to their outstanding biocompatibility and biostability.

VECOLLAN®

...is a recombinant, non-animal-derived collagen-like biomaterial designed for next-generation medical devices. Now available in a clinical-grade, Vecollan® is a sustainable fermentation-based, animal-free collagen alternative, offering high purity and tunable properties.

Bioresorbable biomaterials are designed to safely degrade within the body after fulfilling their function, eliminating the need for surgical removal. These materials are ideal for temporary implants such as sutures, orthopedic pins, and drug delivery systems. Evonik’s RESOMER® range offers a wide range of bioresorbable polymers with tunable degradation rates and mechanical properties. Our VECOLLAN® recombinant collagen-based biomaterial further expands the possibilities for natural, bioresorbable solutions in regenerative medicine and wound healing.

Alternative image
ProductsClass of materialPropertyProcessibiityApplication area
RESOMER®
  • Polylactide
  • Polyglycolide
  • Polycaprolactone
  • Polydioxanone
  • and their co-polymers
Bioresorbable
(Long-term implantable)
VECOLLAN®Recombinant collagen-like peptideBioresorbable
(Long-term implantable)
  • Sponge manufacturing
  • Gel manufacturing
  • Coating
  • Bioprinting

Materials intended for short-term body contact—typically up to 30 days—must meet specific regulatory and performance criteria. Evonik offers a range of materials for applications such as catheters, wound care products, and surgical tools. Our care-grade polymers, including VESTAKEEP®TROGAMID®, and VESTAMID®, are tailored for short-term use. For wound care and medical aesthetics, epicite® provides advanced healing properties, while ENDEXO® surface modification technology enhances the hemocompatibility of medical devices, reducing thrombosis and biofouling.

Alternative image
ProductsClass of materialPropertyProcessibiityApplication area
Endexo®Additive technologyShort-term
up to long-term body contact
Epicite®Biosynthetic celluloseShort-term body contact 
POLYMER VSAddition curing siliconesShort-term
body contact
(Wound care, Explants, etc.)
  • Resin
    formulations
ROHACELL®Polymethacrylimide (PMI)Short-term body contact
 
TROGAMID® CARETransparent polyamides (PA)Short-term body contact
VESTAKEEP® CarePolyether ether ketone polymer ( PEEK)Short-term body contact
VESTAMID® Care MLPolyamide 12 polymer (PA12)Short-term body contact
VESTAMID® Care MEPolyamide 12 elastomers (PEBA)Short-term body contact
VESTENAMER®Trans-polyoctenamer rubber (TOR)Short-term body contact
VESTODUR®Polybutylene terephthalate (PBT)Short-term body contact
VISIOMER®Specialty Methacrylate Monomers

Short-term body contact

Long-term body contact

  • Resin formulations

Devices that remain in the body for more than 30 days require materials with exceptional biostability, mechanical strength, and safety. Evonik’s portfolio includes VESTAKEEP®DEGACRYL®, and DEGAPLAST®, which perform reliably in long-term implantable applications such as orthopedic devices, stents, and spinal implants. These materials are tested for durability and resistance to physiological stress, ensuring consistent performance over the life of the device.

Alternative image
ProductsClass of materialPropertyProcessibiityApplication area
biocellic®Biosynthetic celluloseLong-term body contact 
DEGACRYL®Polymethyl methacrylate (PMMA)Long-term body contact 
DEGAPLAST®Acrylic based resinsLong-term body contact 
NANOCRYL® DNanosilica concentrates for acrylic resinsLong-term body contact
(Artifical teeth)
  • Resin
    formulations

VESTAKEEP® Implant

VESTAKEEP® Dental

VESTAKEEP® Fusion

Polyether ether ketone polymer ( PEEK)Long-term body contact
VISIOMER®Specialty Methacrylate Monomers

Short-term body contact

Long-term body contact

  • Resin formulations


Stories


ANY QUESTIONS LEFT? JUST CONTACT US.

"Our global team of medical devices experts is ready to support you with all questions around our broad portfolio of products and solutions. Contact us to profit from more than 30 years of application know-how in the field of medical devices and find your individual solution!"

 

Dr. Philip Engel
Head of Segment Medical Systems Europe

Alternative image

More about our offerings for medical devices

Alternative image

Biomaterials

Alternative image

Process technologies

Alternative image

Complimentary services